Trademarkia Logo

Australia

AU$
ZETAFUSE
Protected: Registered/protected

Last updated on 22 Apr 2020

Owner Info

Zetagen Therapeutics, Inc.

841 East Fayette Street

Syracuse NY 13210, UNITED STATES OF AMERICA

Serial Number

2045940 filed on 6 Sept 2019

Correspondent

Katherine P. Califa Foley & Lardner LLP

3000 K Street, N.W.,

Sixth Floor,

UNITED STATES OF AMERICA

ZETAFUSE

Classification Information


Class [005]
Pharmaceutical products for the treatment of bone diseases.

Class [010]
Bone setting machines and instruments; medical apparatus and instruments for treating osteoarthritis, osteoporosis, osteotraumatic injuries, degenerat Read More

Mark Details


Serial Number

2045940

Registered On

6 Sept 2019

Renewal On

6 Sept 2029

Mark Type

WORD

Priority Claim (Convention Details)


Date

10 May 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
22nd Apr 2020International Registration in Australia Protected correspondence sent
21st Apr 2020IP Right Registration Published
21st Apr 2020Status change to Registered/Protected
12th Feb 2020Application Accepted correspondence sent
11th Feb 2020IP Right has been Examined
11th Feb 2020IP Right Acceptance Published
11th Feb 2020Status change to Accepted
24th Oct 2019Awaiting examination
24th Oct 2019Examination expedited
24th Oct 2019IP Right Filed Published